These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 362362)
41. [Blood lysozyme contents in patients with nonspecific ulcerous colitis as an index of natural resistance of the organism to infection]. Tumanian MA; Izvekova AV; Levitan MKh; Marko OP Sov Med; 1969 Dec; 32(12):88-90. PubMed ID: 5376026 [No Abstract] [Full Text] [Related]
42. [Bacterial autolysins]. López R; García P; García E Microbiol Esp; 1983; 36(1-2):45-57. PubMed ID: 6381969 [No Abstract] [Full Text] [Related]
43. Proceedings: Abnormalities of splenic function in ulcerative colitis and Crohn's disease. Ryan FP; Preston FE; Smart RC; Holdsworth CD Gut; 1975 Oct; 16(10):834. PubMed ID: 1205306 [No Abstract] [Full Text] [Related]
44. The clinical significance of seromucoids in regional ileitis and ulcerative colitis. COOKE WT; FOWLER DI; COX EV; GADDIE R; MEYNELL MJ Gastroenterology; 1958 May; 34(5):910-9. PubMed ID: 13538157 [No Abstract] [Full Text] [Related]
46. [Muramidase (lysozyme) in differential diagnosis of acute leukemia]. Burchardt K; Wysocki H; Wierusz B; Prazmowska B Acta Haematol Pol; 1974; 5(2):119-25. PubMed ID: 4525400 [No Abstract] [Full Text] [Related]
47. [Lysozyme immunoreactivity levels in blood in patients with various diseases]. Maruden N; Taharaguchi T; Isobe J; Shima K Rinsho Byori; 1988 Mar; 36(3):323-7. PubMed ID: 3404722 [No Abstract] [Full Text] [Related]
48. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
49. Serum lysozyme in Crohn's disease. A useful index of disease activity. Falchuk KR; Perrotto JL; Isselbacher KJ Gastroenterology; 1975 Oct; 69(4):893-6. PubMed ID: 1175883 [TBL] [Abstract][Full Text] [Related]
50. [Studies on blood coagulation in ulcerative colitis and Crohn's disease]. Mori K; Hiwatashi N; Suzuki S; Sugai K; Hisa S; Sakai H; Watanabe H; Endo K; Miura T Rinsho Ketsueki; 1982 Oct; 23(10):1540-8. PubMed ID: 7154258 [No Abstract] [Full Text] [Related]
51. Factors affecting the susceptibility of bacterial cell walls to the action of lysozyme. Work E Proc R Soc Lond B Biol Sci; 1967 Apr; 167(1009):446-7. PubMed ID: 4382811 [No Abstract] [Full Text] [Related]
52. Letter: Lysozyme in Crohn's disease. Pruzanski W; Marcon N N Engl J Med; 1975 Sep; 293(12):611-2. PubMed ID: 1152902 [No Abstract] [Full Text] [Related]
53. Evaluation of 3,4-dinitrophenyl tetra-N-acetyl-beta-chitotetraoside as a substrate for the measurement of lysozyme in normal and pathological sera. Turner GA; Ghneim H; Freeman J Ann Clin Biochem; 1979 Jan; 16(1):51-3. PubMed ID: 420505 [TBL] [Abstract][Full Text] [Related]